Transmedics Group Inc (NASDAQ:TMDX) currently has a daily average trading volume of 1.06M but it saw 369535 shares traded in last market. With a market cap of 4.37B USD, the company’s current market price of $129.19 came rising about 1.17 while comparing to the previous closing price of $127.69. In past 52 weeks, the stock remained buoying in the range of price level as high as $177.37 and as low as $55.00. In the recent trading on the day, stock has struck highest price mark of $124.5 while lowest mark touched by it was $129.19.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the JP Morgan which downgraded the stock as “Neutral” in its note to investors issued on December 17, 2024, recommending a price target of between $116 and $75 for it. Oppenheimer issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $200 and $125.
Over the week, TMDX’s stock price is moving -0.67% down while it is 0.35% when we observe its performance for the past one month. Year-to-date it is -13.98% down and over the past year, the stock is showing an upside performance of 107.20%.
Currently, Transmedics Group Inc’s total number of outstanding shares is 33.83M. Company’s return on investment (ROI) stands at 6.26% and return on equity (ROE) at 22.99%. It has a price to earnings ratio (P/E ratio) of 94.95 while having a 50.92 of forward P/E ratio. Stock’s beta reads 2.10. Stock has a price to book (P/B) ratio of 16.41 while price to sale or P/S ratio amounts to 8.95. Its return on asset (ROA) is 6.27% on average.